Tilt Investment Management Holdings’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$1.12M Sell
10,234
-3,017
-23% -$313K 1.21% 14
2023
Q3
$1.37M Hold
13,251
0.98% 23
2023
Q2
$1.54M Hold
13,251
1.02% 23
2023
Q1
$1.43M Buy
13,251
+1,718
+15% +$185K 1.05% 22
2022
Q4
$1.29M Buy
+11,533
New +$1.18M 1.09% 24

Other funds holding MRK

Tilt Investment Management Holdings's MRK Position: Q4 2023 in Review

Tilt Investment Management Holdings reduced its Merck (MRK) stake by 23% in Q4 2023, selling an estimated $313K and leaving 10,234 shares worth $1.12M. The position accounts for 1.21% of the portfolio, ranked #14.

Tilt Investment Management Holdings first reported a position in MRK in Q4 2022 and has held it in 5 quarters since. The position peaked at $1.54M in Q2 2023. 3,436 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • Tilt Investment Management Holdings held 10,234 shares of Merck worth $1.12M as of Q4 2023.
  • Tilt Investment Management Holdings sold 3,017 Merck shares in Q4 2023, an estimated $313K.
  • Merck made up 1.21% of Tilt Investment Management Holdings's portfolio in Q4 2023, its #14 holding.
  • Tilt Investment Management Holdings first reported a position in Merck in Q4 2022 and has held it in 5 quarters since.
  • Tilt Investment Management Holdings's Merck position peaked at $1.54M in Q2 2023.
  • 3,436 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on Tilt Investment Management Holdings's 13F filing for Q4 2023, filed 31 Jan 2024.